PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058455
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058455
Veterinary Infusion Pump Market is estimated to be valued at USD 125.6 Mn in 2026 and is expected to reach USD 183.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 125.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 183.9 Mn |
Veterinary infusion pump delivers medications and nutrients to patients who cannot administer the drugs orally. These devices has wide application in hospitals to administer drugs in a controlled rate as programmed by the healthcare professional. These pumps offer various advantages over manual administration of medications or any other fluids such as automated delivery of fluids in smaller volumes at preset intervals. High-risk medications for cancer can thus be safely delivered using veterinary infusion pumps. There are two types of veterinary infusion pumps are available in the market including volumetric pumps, and syringe pumps.
The global veterinary infusion market is projected to witness significant growth over the forecast period, owing increased initiatives for prevention and control of pet cancer. For instance, Veterinary Cancer Society organizes one of the largest veterinary oncology meetings in the world, with the goal of bringing together veterinary oncology specialists from around the world to share new information that is obtained through research. Furthermore, Petco Foundation invests in adoption and medical care programs, spay and neuter services, pet cancer research and other initiatives. Petco and Blue Buffalo Foundations supported Penn Vet Cancer Care initiative, Shelter Canine Mammary Tumor Program, for shelter dogs.
Moreover, in January, 2018, Arizona State University was awarded a multi-year grant of US$ 6.4 Mn for Open the Philanthropy Project, as a support to canine clinical trial assessing the effectiveness of a multivalent, preventative cancer vaccine. The trial is expected to test the cancer-prevention efficacy of a Multi-Valent Frameshift Peptide (FSP) vaccine.
The pump failures can have high implications on vet's safety, as these are used for delivering high-risk medications. Thus, the lack of accuracy in delivering the correct volume and dose of fluid can hinder growth of the market. The software problems, alarm errors, and inappropriate user interface design can result in entering inappropriate data whose output leads to incorrect administration of active ingredient in to the vet leading to serious medical issues. Several such existing reported cases are expected to hinder the growth of global veterinary infusion pumps market.